SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders. It has applied ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

SAB’s 9M 2025 net profit rises to SAR 6.41B; Q3 at SAR 2.14B 9 M 2025 SAB profit up 5% to SAR 4.3B in H1 2025; Q2 at SAR 2.1B 6 M 2025 SAB profit rises 5% to SAR 2.13B in Q1 2025 3 M 2025 SAB's 2024 ...

Saigon Beer - Alcohol - Beverage Corporation, together with its subsidiaries, produces and sells beer, alcohol, beverages, and related products and packaging materials under the Bia Saigon, 333, and ...

Real time quote data is not available at this time. Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute.